Invention Grant
- Patent Title: Glycan-interacting compounds and methods of use
-
Application No.: US15775410Application Date: 2016-11-10
-
Publication No.: US11028181B2Publication Date: 2021-06-08
- Inventor: David A. Eavarone , Jillian M. Prendergast , Jeffrey Behrens
- Applicant: Seagen Inc.
- Applicant Address: US WA Bothell
- Assignee: Seagen Inc.
- Current Assignee: Seagen Inc.
- Current Assignee Address: US WA Bothell
- Agency: McNeill Baur PLLC
- International Application: PCT/US2016/061427 WO 20161110
- International Announcement: WO2017/083582 WO 20170518
- Main IPC: C07K16/30
- IPC: C07K16/30 ; A61K47/68 ; A61K39/00
Abstract:
The present invention provides glycan-interacting antibodies and methods for producing glycan-interacting antibodies useful in the treatment and prevention of human disease, including cancer. Such glycan-interacting antibodies include humanized antibodies, derivatives and fragments thereof as well as related compositions and kits. Methods of using glycan-interacting antibodies for treatment and diagnosis are included.
Public/Granted literature
- US20180327509A1 GLYCAN-INTERACTING COMPOUNDS AND METHODS OF USE Public/Granted day:2018-11-15
Information query
